Pure Global Cannabis Inc · OTC:PRCNF
Pure Global Cannabis — Investor Presentation (October 2019)
23 slides from Pure Global Cannabis's investor presentation, October 2019
Slide 1: Investing in the Next Generation of Cannabis
Investing in the Next Generation of Cannabis TSX.V:PURE | OTC:PRCNF | FRA:1QS OCTOBER 2019
Slide 2: Disclaimer
Disclaimer Certain information here may constitute “forward-looking information” under Canadian securities legislation. Generally forward looking information can be identified by the use of forward-looking terminology, such as “expects” or “it is expected”, or variations of such words, phrases and s
Slide 3: Our Vision, Our Purpose
Our Vision Our Purpose Using science and data to To make a positive unravel the therapeutic difference in every life effects of cannabinoids, we touch, each and manufacturing trusted bulk, every day. consumer and pet products, and commercializing them globally. 310 | TSX.V:PURE | TSX.V:PUREI OTC:PRC
Slide 4: The Pure Global Value Proposition
The Pure Global Value Proposition We focus first and foremost on the well being of our customers. The Right People Science & Data Strategic Business Model We invest in the right people that are We take a science and data based We have created a business model focused committed to improving customer
Slide 5: Milestones Achieved
Milestones Achieved Dec 2017 Sept 2018 Jan 2019 Aug 2019 Cultivation License $10M convertible Sales Licensing Completion Phase 2 - Phase 1 raise dried flower Readiness submission March 2014 July 2018 Acquisition – Spark Cannabis Incorporation RTO TSX.V Clinic + $11M equity raise Sept 2019 August 201
Slide 6: Science-based Decision Making
Science-based Decision Making We are taking a science and data based approach to all our decision making. Science, and the data behind it, will determine our path. The market is looking for viability. Consumers need trusted products that provide predictable outcomes. Pure aims to become a leader in
Slide 7: Our Core Business: Manufacturing
Our Core Business Pure has been structured to focus on cannabinoid manufacturing, through cultivation and extraction, and creating sustainable differentiation through continued innovations, branding, and development of intellectual property. Manufacturing Installed and Ready CO2 Extraction + Distill
Slide 8: Best-in-Class Capabilities
Best-in-Class Capabilities We utilize cutting-edge cultivation technology that can produce higher quality product with significantly greater yields. Our Chief Manufacturing Officer, Nader Gheshlaghi, is a world-renowned large-scale indoor/outdoor agriculture engineer and biotechnologist who has buil
Slide 9: State-of-the-Art Facilities
State-of-the-Art Facilities Brampton, Ontario • Facility consists of two structures (18,000 and 23,000 sq. ft.) that are being built out over three phases in accordance with euGMP and pharmaceutical standards • Phase 1 is complete and comprises one third of the first building containing facilities f
Slide 10: China Large Scale CBD Manufacturing
“We are the first Canadian LP to be China Large Scale CBD Manufacturing licensed to operate in China!” – CEO Pure Global, Malay Panchal To secure the lowest cost large scale CBD bulk manufacturing capability, Pure went to China and has entered into a long-term strategic joint venture with KMT-Hansa
Slide 11: PureCanna Solutions – Main Revenue Center
PureCanna Solutions – Main Revenue Center B2B brand focused on CBD/THC bulk sales, distribution, co-manufacturing services, resulting in projected high-margin high-volume sales. Bulk Distillate and Isolate Sales White Label Sales and Services and Extraction Services Co-packaging/Co-manufacturing • 6
Slide 12: Research & Development
Research & Development T h e pi ct ur e c Cannabinoid Research a n' t b • Utilizing our in-house research lab, along with collaborations with researchers around e di the world, to develop novel natural health and pharmaceutical products s pl a • Goal is to unravel the mysteries of the endocannabinoi
Slide 13: Cannabis Health Products (CHPs)
Cannabis Health Products (CHPs) New category of cannabinoid based health products introduced by Health Canada that need to be evidence backed. Permits certain cannabis-based health products to be sold without a prescription under the following proposed framework: • Specific health claims would have
Slide 14: Our Brand Pipeline
Our Brand Pipeline We create premium, strategically positioned consumer-centric passion brands, that focus foremost on delivering an exceptional client experience, driven by trust. Pure is leading the We are building organic Our brands will deliver Brands are based on evolution of the brand equity b
Slide 15: Current Products
Current Products 12 | TSX.V:PURE 1510 | TSX.V:PURE I OTC:PRCNF | TSX.V:PURE I OTC:PRCNFIII FRA:lQS I OTC:PRCNF FRA:lQS FRA:lQS
Slide 16: Distribution
Distribution Canadian Velvet Management Inc. • Partnered with Velvet to be Pure’s Canadian sales and distribution agent • Velvet, created by the largest wine distributor in Canada, Philippe Dandurand Wines, is focused on providing product sales and distribution to provincial cannabis wholesalers wit
Slide 17: Strategic Partnerships
Strategic Partnerships We have developed strategic relationships with industry-leading companies that share our goals and vision. Commercial Clinical 10 | TSX.V:PURE 1710 | TSX.V:PURE I OTC:PRCNF | TSX.V:PURE I OTC:PRCNFIII FRA:lQS I OTC:PRCNF FRA:lQS FRA:lQS
Slide 18: Experienced Successful Management Team
Experienced Successful Management Team Malay Panchal, RPh, BScPhm Bhup Gosain, CPA, CA, CPA (IL) Nader Gheshlaghi Founder, President & CEO Chief Financial Officer Chief Manufacturing Officer Malay is a pharmaceutical professional and seasoned 30+ years experience in tax and business advisory service
Slide 19: Board of Directors
Board of Directors Dr. Chandra Panchal, PhD Malay Panchal, RPh, BScPhm Jane Pagel, MSc Chairman President & CEO Board Member Distinguished resume includes Director for MaRS Innovation, Malay is a pharmaceutical professional and seasoned Retired executive with extensive experience, previously held se
Slide 20: Financials
Financials TSX.V:PURE ROUNDED* Issued & Outstanding 158.6M Warrants & Options 48.5M Fully Diluted 207M Cash and A/R** $2.8M Debt*** $12.3M Shares Reserved**** 20.8M * As of June 30, 2019 ** This includes cash, receivables, and sales tax receivables *** Debt includes Vendor Take Back of $4.9M and con
Slide 21: Catalysts Ahead
Catalysts Ahead Catalysts Estimated Timeframe Phase 2 approvals for cultivation and extraction rooms Est. within 60 days Manufacturing upgrade – 100+ tons biomass extraction Ready early 2020 Medical European distribution LOIs – Germany Now to Q1 2020 First harvest Phase 2 Early 2020 CBD bulk sales E
Slide 22: Rights of Purchasers
Rights of Purchasers Securities legislation in certain of the Canadian provinces provide purchasers of securities pursuant to an offering memorandum (such as this presentation) with a remedy for damages or rescission, or both, in addition to any other rights they may have at law, where the offering
Slide 23: Invest. Relax. Repeat.
Invest. Relax. Repeat. Malay Panchal President & CEO Stephen Pynn VP, Corporate Development [email protected] 1-866-840-PURE (7873)
Pure Global Cannabis — Investor Presentation (October 2019) on 6ix